In summary, our results show, for the first time, that ATRA enhances MMP-2 expression and secretion in human myeloid leukemia THP-1 cells in a calcium ion dependent manner through RAR-dependent and independent signaling pathways, and this enhanced secretion was reversed by dexamethasone treatment. Here, RARA is linked to myeloid leukemia.